Efficacy, Tolerability, and Safety of DFN-15
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Celecoxib (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 30 Jan 2018 Planned End Date changed from 1 Mar 2018 to 1 May 2018.
- 20 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Jan 2017 New trial record